TerminatedNCT03158298
Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jena University Hospital
- Principal Investigator
- Benjamin Schleenvoigt, M.D.Center for Infectious Diseases and Infection Control, Jena University Hospital
- Intervention
- Specimen collection(other)
- Enrollment
- 82 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2017 – 2019
Study locations (1)
- University Hospital Jena, Jena, Thuringia, Germany
Collaborators
Technical University of Munich · Charite University, Berlin, Germany · University Hospital in Halle
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03158298 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06698510Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyPeter Steinmann
- RECRUITINGNANCT06873308Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic SchistosomiasisIRCCS Sacro Cuore Don Calabria di Negrar